PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.\', \'Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.\', \'Clalit Health Services, Tel-Aviv, Israel.\', \'Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.\', \'Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.\', \'Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.\', \'Baruch Padeh Medical Center, Tiberias, Israel.\', \'Department of Behavioral Sciences, Ariel University, Ariel, Israel.\', \'Sial Research Center, Division of Community Health, Ben Gurion University of the Negev, Beer Sheva, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/dth.15003
?:hasPublicationType
?:journal
  • Dermatologic therapy
is ?:pmid of
?:pmid
?:pmid
  • 34033207
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.625
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all